Physician profile
Lev Tomashevsky
NPI 1962407338
$1,115.17
in general payments reported to CMS, 2019-2025
13 companies · $201 in 2025
The $201 reported for 2025 was more than what 75% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.20 · 2020: $212 · 2021: $382 · 2022: $19.32 · 2023: $104 · 2024: $121 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $404.86 | 2020-2025 | Invisalign |
| Zimmer Biomet Holdings, INC. | $265.75 | 2020-2021 | |
| Zimvie INC. | $183.70 | 2022-2025 | |
| Kettenbach LP | $49.99 | 2019 | |
| Patterson Companies, INC. | $49.93 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $34.43 | 2025 | Cobenfy |
| 3m Company | $33.40 | 2021 | |
| Ss White Burs LLC | $19.38 | 2020 | |
| Solventum Corporation | $19.07 | 2025 | 3m Scotchbond, 3m Filtek, Relyx Unicem Aplicap |
| Henry Schein, INC. | $16.33 | 2019 | |
| Zest Holdings, LLC | $14.86 | 2025 | |
| Straumann USA LLC | $13.59 | 2025 | |
| Voco America INC. | $9.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lev Tomashevsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.